ReviewFrontiers in immunology2026
MERS-CoV accessory ORF proteins in innate immune evasion: an evidence-graded functional framework.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a merbecovirus associated with recurrent zoonotic spillover and severe lower-respiratory disease. Research has focused largely on DPP4-mediated entry, spike structure, replicase biology, neutralizing antibodies, and vaccines. However, the 3'-encoded accessory proteins are increasingly recognized as context-dependent modulators of viral fitness and pathogenesis. ORF4a binds double-stranded RNA (dsRNA) and suppresses MDA5- and PKR-dependent antiviral responses; ORF4b antagonizes OAS-RNase L and NF-κB signaling and contributes to inflammatory pathology in defined infection models; ORF5 modulates interferon and inflammatory responses in a genetic-background-dependent manner; and ORF8b interferes with MDA5- and HSP70-IKKϵ-dependent signaling, although its pathogenesis phenotype varies by experimental system and viral background. ORF3 shows HUWE1-regulated pro-apoptotic activity in ectopic-expression systems, but its role during authentic MERS-CoV infection remains unresolved. Our review organizes these findings by evidence type, pathway position, cell or tissue context, sampling time, and genetic-interaction evidence. This framework separates demonstrated mechanisms from inferred biological consequences and identifies the validation required before accessory-ORF biology can inform host-range assessment, therapeutic development, sequence surveillance, or rational attenuation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.